Gambling symptom severity · treatment of disordered and problem gambling
1 finding from 1 review
Gambling expenditure · treatment of disordered and problem gambling
1 finding from 1 review
Gambling frequency ‐ not measured · treatment of disordered and problem gambling
1 finding from 1 review
Time spent gambling ‐ not measured · treatment of disordered and problem gambling
1 finding from 1 review
Depressive symptoms · treatment of disordered and problem gambling
1 finding from 1 review
Anxiety · treatment of disordered and problem gambling
1 finding from 1 review
Functional impairment · treatment of disordered and problem gambling
1 finding from 1 review
Responder status · treatment of disordered and problem gambling
It is very uncertain whether mood stabilisers changes responder status compared with placebo (very low certainty).
1 finding from 1 review
BPD symptom severity Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder
1 finding from 1 review
Self‐harm Measured by: clinicians Timing of outcome assessment: end of treatment · patients with borderline personality disorder
It is very uncertain whether mood stabilisers changes self‐harm Timing of outcome assessment: end of treatment (52 weeks… compared with placebo (very low certainty).
1 finding from 1 review
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with borderline personality disorder
1 finding from 1 review
Psychosocial functioning Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder
1 finding from 1 review
Interpersonal problems Timing of outcome assessment: end of treatment (32 days to 24 weeks) · patients with borderline personality disorder
1 finding from 1 review
Attrition Timing of outcome assessment: end of treatment · patients with borderline personality disorder
Mood stabilisers may leads to lower attrition Timing of outcome assessment: end of treatment (32 days to… compared with placebo (low certainty).
1 finding from 1 review
Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder
It is very uncertain whether mood stabilisers changes non‐serious adverse events Timing of outcome assessment: end of… compared with placebo (very low certainty).
1 finding from 1 review
Repetition of SH at 12 months · adults who engage in SH
Mood stabilisers showed no clear difference in repetition of SH at 12 months compared with placebo (low certainty).
1 finding from 1 review
Abstinence · cannabis dependence
It is very uncertain whether anticonvulsants and mood stabilisers changes participants abstinent at end of treatment compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · cannabis dependence
It is very uncertain whether anticonvulsants and mood stabilisers changes participants withdrawn due to adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Completion of scheduled treatment · cannabis dependence
Anticonvulsants and mood stabilisers may leads to lower completion of scheduled treatment compared with placebo (low certainty).
1 finding from 1 review
Repetition of SH at post‐intervention · self‐harm in adults
It is very uncertain whether mood stabilisers, including antiepileptics and lithium changes repetition of SH by post‐intervention№ of participants: 167(1 RCT) compared with placebo (very low certainty).
1 finding from 1 review
OR 0.99 [0.33, 2.95]
Studies not reported
Very low